So far 15 patients underwent surgery in the proof-of-concept study, according to an Oct. 17 news release.
“This is an important goal for the study: addressing the need for non-narcotic pain management therapy earlier on to avert the need for opioids,” Rohan Lall, MD, a co-investigator on the study, said in the release. “If the SynerFuse e-TLIF procedure proves effective at lowering post-operative pain levels, as early indications have suggested, we may have a new treatment strategy that potentially saves the healthcare system billions of dollars and improves pain management outcomes.”
